1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
Delayed Xetra  -  05/20 11:35:26 am EDT
19.63 EUR   +2.83%
05/20European ADRs Move Sharply Higher in Friday Trading
MT
05/19MorphoSys AG Reports Outcome of Annual General Meeting 2022
AQ
05/18MorphoSys AG Reports Outcome of Annual General Meeting 2022
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MORPHOSYS : JP Morgan sticks Neutral

05/13/2022 | 10:21am EDT

JP Morgan analyst James Gordon maintains his Neutral opinion on the stock. The target price is unchanged at EUR 34.


© MarketScreener with dpa-AFX Analyser 2022
All news about MORPHOSYS AG
05/20European ADRs Move Sharply Higher in Friday Trading
MT
05/19MorphoSys AG Reports Outcome of Annual General Meeting 2022
AQ
05/18MorphoSys AG Reports Outcome of Annual General Meeting 2022
EQ
05/18MorphoSys AG Announces Supervisory Board Changes
CI
05/13European ADRs Move Higher in Friday Trading
MT
05/13MORPHOSYS : JP Morgan sticks Neutral
MD
05/12MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022..
EQ
05/12MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022..
BU
05/11MORPHOSYS : JP Morgan reiterates its Neutral rating
MD
05/06European ADRs Move Lower in Friday Trading
MT
More news
Analyst Recommendations on MORPHOSYS AG
More recommendations
Financials
Sales 2022 244 M 257 M 257 M
Net income 2022 -276 M -292 M -292 M
Net cash 2022 396 M 418 M 418 M
P/E ratio 2022 -2,43x
Yield 2022 -
Capitalization 670 M 707 M 707 M
EV / Sales 2022 1,12x
EV / Sales 2023 1,34x
Nbr of Employees 652
Free-Float 99,7%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,63 €
Average target price 44,33 €
Spread / Average Target 126%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Malte Peters Chief Research & Development Officer
Daniel Palmacci Global Head-Technical Operations
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG-41.14%707
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567